Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.
Lukasik, Maria
Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke. [electronic resource] - Thrombosis and haemostasis Feb 2012 - 346-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2567-689X
10.1160/TH11-05-0345 doi
Aged
Aged, 80 and over
Biomarkers--metabolism
Blood Platelets--immunology
CD40 Ligand--genetics
Cell Aggregation
Female
Follow-Up Studies
Humans
Inflammation Mediators--metabolism
Male
Middle Aged
Monocytes--immunology
P-Selectin--metabolism
Predictive Value of Tests
Prognosis
Prospective Studies
Stroke--diagnosis
Survival Analysis
Up-Regulation
Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke. [electronic resource] - Thrombosis and haemostasis Feb 2012 - 346-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2567-689X
10.1160/TH11-05-0345 doi
Aged
Aged, 80 and over
Biomarkers--metabolism
Blood Platelets--immunology
CD40 Ligand--genetics
Cell Aggregation
Female
Follow-Up Studies
Humans
Inflammation Mediators--metabolism
Male
Middle Aged
Monocytes--immunology
P-Selectin--metabolism
Predictive Value of Tests
Prognosis
Prospective Studies
Stroke--diagnosis
Survival Analysis
Up-Regulation